Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999–2012. JAMA. 2015;314(17):1818–31. https://doi.org/10.1001/jama.2015.13766.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qato DM, Wilder J, Schumm P, Gillet V, Alexander GC. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176(4):473–82. https://doi.org/10.1001/jamainternmed.2015.8581.

Article  PubMed  PubMed Central  Google Scholar 

Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65. https://doi.org/10.1517/14740338.2013.827660.

Article  PubMed  Google Scholar 

Becker ML, Kallewaard M, Caspers PWJ, Visser LE, Leufkens HGM, Stricker BH. Hospitalisations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2007;16(6):641–51. https://doi.org/10.1002/pds.1351.

Article  PubMed  Google Scholar 

Dechanont S, Maphanta S, Butthum B, Kongkaew C. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2014;23(5):489–97. https://doi.org/10.1002/pds.3592.

Article  PubMed  Google Scholar 

Magro L, Moretti U, Leone R. Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions. Expert Opin Drug Saf. 2012;11(1):83–94. https://doi.org/10.1517/14740338.2012.631910.

Article  CAS  PubMed  Google Scholar 

Shehab N, Lovegrove MC, Geller AI, Rose KO, Weidle NJ, Budnitz DS. US emergency department visits for outpatient adverse drug events, 2013–2014. JAMA. 2016;316(20):2115–25. https://doi.org/10.1001/jama.2016.16201.

Article  PubMed  PubMed Central  Google Scholar 

Leonard CE, Brensinger CM, Bilker WB, Kimmel SE, Han X, Nam YH, Gagne JJ, Mangaali MJ, Hennessy S. Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics. Int J Cardiol. 2017;228:761–70. https://doi.org/10.1016/j.ijcard.2016.11.245.

Article  PubMed  Google Scholar 

Bykov K, Schneeweiss S, Glynn R, Mittleman MA, Gagne JJ. A case-crossover-based screening approach to identifying clinically relevant drug-drug interactions in electronic healthcare data. Clin Pharmacol Ther. 2019;106(1):238–44. https://doi.org/10.1002/cpt.1376.

Article  CAS  PubMed  Google Scholar 

Han X, Chiang CW, Leonard CE, Bilker WB, Brensinger CM, Li L, Hennessy S. Biomedical Informatics approaches to identifying drug-drug interactions application to insulin secretagogues. Epidemiology. 2017;28(3):459–68. https://doi.org/10.1097/Ede.0000000000000638.

Article  PubMed  PubMed Central  Google Scholar 

Leonard CE, Bilker WB, Brensinger CM, Han X, Flory JH, Flockhart DA, Gagne JJ, Cardillo S, Hennessy S. Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics. Clin Pharmacol Ther. 2016;99(5):538–47. https://doi.org/10.1002/cpt.297.

Article  CAS  PubMed  Google Scholar 

Nam YH, Brensinger CM, Bilker WB, Leonard CE, Han X, Hennessy S. Serious hypoglycemia and use of warfarin in combination with sulfonylureas or metformin. Clin Pharmacol Ther. 2019;105(1):210–8. https://doi.org/10.1002/cpt.1146.

Article  CAS  PubMed  Google Scholar 

Abrahamsson T, Berge J, Ojehagen A, Hakansson A. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study. Drug Alcohol Depend. 2017;174:58–64. https://doi.org/10.1016/j.drugalcdep.2017.01.013.

Article  CAS  PubMed  Google Scholar 

Fried TR, O’Leary J, Towle V, Goldstein MK, Trentalange M, Martin DK. health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62(12):2261–72. https://doi.org/10.1111/jgs.13153.

Article  PubMed  PubMed Central  Google Scholar 

Nobili A, Pasina L, Tettamanti M, Lucca U, Riva E, Marzona I, Monesi L, Cucchiani R, Bortolotti A, Fortino I, Merlino L, Locatelli GW, Giuliani G. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther. 2009;34(4):377–86. https://doi.org/10.1111/j.1365-2710.2009.01021.x.

Article  CAS  PubMed  Google Scholar 

Qato DM, Ozenberger K, Olfson M. Prevalence of prescription medications with depression as a potential adverse effect among adults in the United States. JAMA. 2018;319(22):2289–98. https://doi.org/10.1001/jama.2018.6741.

Article  PubMed  PubMed Central  Google Scholar 

Chiang CW, Zhang PY, Wang XY, Wang L, Zhang SJ, Ning X, Shen L, Quinney SK, Li L. Translational high-dimensional drug interaction discovery and validation using health record databases and pharmacokinetics models. Clin Pharmacol Ther. 2018;103(2):287–95. https://doi.org/10.1002/cpt.914.

Article  CAS  PubMed  Google Scholar 

CDC. Health, United States; 2018 [01/25/2020]. https://www.cdc.gov/nchs/data/hus/2018/038.pdf.

John R, Philip D. Although triple drug interactions are not well studied, available information points to some general principles that may be useful in managing such combination. Pharmacy Times; 2011 [01/25/2020]. https://www.pharmacytimes.com/publications/issue/2011/January2011/Interactions-0111.

Harpaz R, Chase HS, Friedman C. Mining multi-item drug adverse effect associations in spontaneous reporting systems. BMC Bioinform. 2010;11(Suppl 9):S7. https://doi.org/10.1186/1471-2105-11-S9-S7.

Article  Google Scholar 

Xiang Y, Albin A, Ren K, Zhang P, Etter JP, Lin S, Li L. Efficiently mining Adverse Event Reporting System for multiple drug interactions. AMIA Jt Summits Transl Sci Proc. 2014;2014:120–5.

PubMed  PubMed Central  Google Scholar 

Chasioti D, Yao X, Zhang P, Lerner S, Quinney SK, Ning X, Li L, Shen L. Mining directional drug interaction effects on myopathy using the FAERS database. IEEE J Biomed Health Inform. 2019;23(5):2156–63. https://doi.org/10.1109/JBHI.2018.2874533.

Article  PubMed  Google Scholar 

Wang X, Zhang P, Chiang CW, Wu H, Shen L, Ning X, Zeng D, Wang L, Quinney SK, Feng W, Li L. Mixture drug-count response model for the high-dimensional drug combinatory effect on myopathy. Stat Med. 2018;37(4):673–86. https://doi.org/10.1002/sim.7545.

Article  PubMed  Google Scholar 

CMS. Medicare Claims Processing Manual 2019 [01/25/2020]. https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/downloads/R1139CP.pdf.

RxNorm. https://www.nlm.nih.gov/research/umls/rxnorm/index.html.

U.S. Department of Health and Human Services OoDPaHP. National Action Plan for Adverse Drug Event Prevention. Washington, DC; 2014.

Digmann R, Thomas A, Peppercorn S, Ryan A, Zhang L, Irby K, Brock J. Use of medicare administrative claims to identify a population at high risk for adverse drug events and hospital use for quality improvement. J Manag Care Spec Pharm. 2019;25(3):402–10. https://doi.org/10.18553/jmcp.2019.25.3.402.

Article  PubMed  Google Scholar 

Wedemeyer RS, Blume H. Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update. Drug Saf. 2014;37(4):201–11. https://doi.org/10.1007/s40264-014-0144-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wintzell V, Svanstrom H, Pasternak B. Selection of comparator group in observational drug safety studies: alternatives to the active comparator new user design. Epidemiology. 2022;33(5):707–14. https://doi.org/10.1097/EDE.0000000000001521.

Article  PubMed  Google Scholar 

Yoshida K, Solomon DH, Kim SC. Active-comparator design and new-user design in observational studies. Nat Rev Rheumatol. 2015;11(7):437–41. https://doi.org/10.1038/nrrheum.2015.30.

Article  CAS  PubMed  PubMed Central  Google Scholar